More visibility for pathologists
For several decades pathologists worldwide have been under increasing pressure to handle a steady increase in laboratory tests with a steady decrease in finance and staff.
System detects MRSA in less than 90 minutes
The GenSPEED Test System developed by Greiner Bio-One combines crude lysis of bacteria with multiplex-PCR before the final automated analysis of PCR-products in the new GenSPEED R2 device.
Researching the genetic causes of infectious and congenital immunodeficiency disorders
The Robert Koch Award will be shared between Professors Casanova and Fischer; Professor Bujard is being awarded the Robert Koch Gold Medal
Protein test instead of cystoscopy
A recent study from the Heidelberg-based company Sciomics, a spin-off from scientists from the German Cancer Research Center (DKFZ), has presented an advanced method to predict the recurrence of bladder cancer after surgery. The method, which can help avoid frequent cystoscopy examinations in a majority of patients, is based on an analysis of the protein composition of cancer tissue obtained…
New trends in Pathology Informatics
For several decades, pathologists worldwide have been under increasing pressure to handle a steady increase in laboratory tests with a steady decrease in the amount of financial and staff resources. Add to this the escalating volume of increasingly complex, sophisticated testing and the importance of pathology informatics is evident.
Same-day diagnosis from hand-held device
Scientists in the UK are working to develop a hand-held testing device to provide same day diagnosis from a patient’s bedside. The device will use disposable cartridges and utilise printed circuit board technology (PCB) that will allow a fast and low-cost diagnosis.
Delayed diagnoses result in high mortality
Sepsis kills around 130 patients daily In Germany alone. This systemic disease is mostly caused by bacterial pathogens, and less frequently by fungal organisms or parasites. Professor Dr Frank M Brunkhorst of the Centre of Sepsis Control and Care (CSCC), at Jena University Hospital, Germany, is seeking strategies to combat such scary figures.
CLICK – and tumour growth is known in seconds
Some years ago telepathology – a complex but well developed procedure where histology specimens are photographed using a camera mounted on a microscope and transmitted – was thought to be the wave of the future.
Danes take pathology software worldwide
Having convinced medical labs across Denmark that its suite of image analysis software can provide a solution to the crushing burden of in vitro diagnostics (IVD), VisioPharm is offering it to pathologists worldwide
Oocyte modification
USA - Oocyte modification to eliminate inherited mitochondrial defects in a human embryo was the subject of a globally scrutinised Food and Drug Administration (FDA) hearing held in February.
Article • Clinical chemistry
THE AACC FORUM 2014
This April, in San Jose, California, the portable lab took central stage at the American Association for Clinical Chemistry’s (AACC) annual forum for emerging clinical diagnostic technologies – a most appropriate topic for the Silicon Valley venue where so many world-changing computer and communications innovations have been born.
Radiometer acquires HemoCue
Two companies with similar core values, providing high quality products for acute care and point-of-care testing worldwide.
Infections in joint surgery: high risk for fracture patients
Postoperative infections after knee or hip joint replacements are among the most feared complications in orthopaedic surgery. At the EFORT Congress in London current research was presented that provides new insights in this field: Fracture patients are especially vulnerable to infection. New biomarkers should improve early diagnosis of risky infections.
Personalised Medicine Drives Uptake
Future of DNA sequencing will shift from a laboratory-based setup to point of care testing in the next 5 years
One tube for comprehensive urine diagnostics
Reliable results can only be achieved in urine diagnostics, if correct preanalytical conditions are ensured. Urine collection, specimen transport and further storage are critical influential factors for sample quality and can affect the results.
Mobile POC applications and educational resources
‘Physicians and clinicians treating patients at the point of care (POC) can benefit greatly from easy access to materials and resources via their handheld devices,’ comments Jamie Gramz, Director of Global Marketing at Siemens Healthcare Diagnostics.
Curse or blessing?
A small prick to sample blood instead of complex pathological or other diagnostic procedures – this is how early cancer diagnosis will be in the near future. Blood tests to diagnose tumorous diseases early are already being researched for clinical use.
Sectra brings PACS power to pathology
"I can count on my fingers the number of pathologists who work full digitally," said Elin Kindberg who is leading the development of a pathology PACS for Sectra Imaging IT Solutions. Conventional light microscopes continued to be standard tool for examining histo-pathology slides.
‘Huge progress’ in the ICU
You’ll find Élie Azoulay everywhere during this year’s International Symposium on Intensive Care and Emergency Medicine (ISICEM).
Brain has switch board to guide behavior in response to external stimuli
How do our brains combine information from the external world (sensory stimulation) with information on our internal state such as hunger, fear or stress?
A challenge for oncologists
‘The disease “cancer” is increasingly classified into sub-groups. Today, we are already dealing with a number of orphan diseases,’ says Professor Richard Greil MD, head of LIMCR at University Hospital Salzburg.
Virtual microscope images at your fingertips
Olympus launches its OlyVIA Mobile iPad App, an image viewer dedicated to virtual slides.
Small size in early pregnancy linked to poor heart health later in life
Poor growth in the first three months of pregnancy is associated with a range of cardiovascular risk factors in childhood, finds a study published on bmj.com.
Automated Anatomic Pathology Labs Transform Diagnostics
Offering attractive procurement strategies will boost adoption of high-end tools
Article • 123
Earlier detection of Down’s syndrome
Down’s syndrome (also referred to as trisomy 21) is a genetic disorder caused by the presence of all or part of an extra copy of chromosome 21 in a person’s DNA. Current screening for Down’s syndrome and other trisomy conditions includes a combined test done between the 11th and 13th weeks of pregnancy.